Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer
British Journal of Cancer, 09/16/09
Kosmas C et al. – Recurrent or metastatic cervical cancer represents an aggressive malignancy with a high rate of locoregional and distant failure. TIP is an active regimen with acceptable toxicity in advanced/relapsed cervical cancer.
C Kosmas, 09/16/09
| The Paclitaxel-Ifosfamide-Cisplatin (TIP) regimen appears to be active and relatively tolerable, except some slightly excessive (approx. 20%) rate of febrile neutropenic episodes, which are rapidly reversible mostly with home antibiotic therapy (amoxicillin/clavulanate+ciproxin). The regimen has shown to be highly active in patients with relapses outside previously irradiated pelvic sites, in particular lymph nodes and pulmonary metastases. Moreover, about 15% of patients with para-aortic lymph node metastases have experienced >2-year survival. |
Related Articles
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study : The Lancet Oncology
The Lancet Oncology - Online First, 10/12/09
Relevance Score: 70%
Transvaginal doppler sonography for assessment the response to radiotherapy in locally advanced squamous cervical cancer: a preliminary study
Archives of Medical Science, 11/03/09
Relevance Score: 69%
Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09
Relevance Score: 69%
A survey of the knowledge and attitude of Jordanian obstetricians and gynaecologists to cervical cancer screening
Journal of Obstetrics and Gynaecology, 10/29/09
Relevance Score: 69%
Interleukin-12 gene polymorphism and cervical cancer risk
American Journal of Clinical Oncology, 10/06/09
Relevance Score: 69%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Endometrial Carcinomas in Women Aged 40 Years and Younger: Tumors Associated With Loss of DNA Mismatch Repair Proteins Comprise a Distinct Clinicopathologic Subset
American Journal of Surgical Pathology , 12/08/09
The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma
Human Pathology, 12/07/09
Papillary squamous intraepithelial lesions of the uterine cervix: human papillomavirus-dependent changes in cell cycle expression and cytologic features
Human Pathology, 12/07/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer
Anti-Cancer Drugs, 12/08/09
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
Anti-Cancer Drugs, 12/08/09
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma
British Journal of Haematology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


